NCT02147015View on ClinicalTrials.gov

Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPD

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Glucocorticoids

DRUG

Antibiotics

DRUG

Inhaled corticosteroid (ICS)

DRUG

Long-Acting Muscarinic Antagonists(LAMA)

DRUG

Short-acting beta2-agonist (SABA)

OTHER

Physical treatments

DRUG

long-acting beta2-agonist (LABA)

Trial Locations (1)

400042

Daping Hospital, Chongqing

All Listed Sponsors
lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER

NCT02147015 - Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPD | Biotech Hunter | Biotech Hunter